Literature DB >> 25163944

Enhanced recovery programme for total knee replacement to reduce the length of hospital stay.

Amitabh J Dwyer1, William Thomas, Simon Humphry, Paul Porter.   

Abstract

PURPOSE: To compare the length of hospital stay in patients undergoing primary total knee replacement (TKR) with or without enhanced recovery (ER) programme.
METHODS: Medical records of 57 and 55 consecutive patients who underwent primary TKR with or without ER programme, respectively, were reviewed. 17 men and 40 women aged 43 to 87 (mean, 70) years with ER programme were compared with 22 men and 33 women aged 53 to 90 (mean, 73) years without ER programme in terms of the preoperative haemoglobin level, American Association of Anesthesiologists (ASA) physical status grading, body mass index (BMI), and length of hospital stay.
RESULTS: The length of hospital stay was significantly shorter in the ER than non-ER groups in overall patients (6 vs. 7.8 days, p=0.0003), in patients with preoperative haemoglobin level of ≥ 14 g/dl (5.4 vs. 7.7 days, p=0.02), in patients with preoperative haemoglobin level of <14 g/dl (6.2 vs. 7.7 days, p=0.02), in patients with ASA grades 1 and 2 (5.6 vs. 7.6 days, p=0.01), in patients with ASA grade 3 (6.4 vs. 8.2 days, p=0.01), in patients with BMI of <30 kg/m(2) (6 vs. 8.1 days, p=0.0061), and in patients with BMI of ≥ 30 kg/m(2) (5.9 vs. 7.5 days, p=0.0006). Complications were noted in 4 ER patients and 5 non-ER patients.
CONCLUSION: ER programmes are readily transferable to patients undergoing TKR and significantly reduced the length of hospital stay.

Entities:  

Keywords:  arthroplasty, replacement, knee; length ofzzm321990stay; postoperative care

Mesh:

Substances:

Year:  2014        PMID: 25163944     DOI: 10.1177/230949901402200206

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  7 in total

1.  Enhanced recovery programme reduces opiate consumption in hip hemiarthroplasty.

Authors:  Rupert Talboys; Mandy Mak; Nitin Modi; Nabil Fanous; Steven Cutts
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-11-11

2.  Drivers of in-hospital opioid consumption in patients undergoing lumbar fusion surgery.

Authors:  Yoji Ogura; Jeffrey L Gum; Portia Steele; Charles H Crawford; Mladen Djurasovic; R Kirk Owens; Joseph Laratta; Morgan Brown; Christy Daniels; John R Dimar; Steven D Glassman; Leah Y Carreon
Journal:  J Spine Surg       Date:  2021-03

3.  Multi-modal pain control regimen for anterior lumbar fusion drastically reduces in-hospital opioid consumption.

Authors:  Yoji Ogura; Jeffrey L Gum; Portia Steele; Charles H Crawford; Mladen Djurasovic; R Kirk Owens; Joseph L Laratta; Eric Davis; Morgan Brown; Christy Daniels; John R Dimar; Steven D Glassman; Leah Y Carreon
Journal:  J Spine Surg       Date:  2020-12

4.  Time-driven activity-based costing of total knee replacements in Karachi, Pakistan.

Authors:  Rabia Mansoor Khan; Katherine Albutt; Muhammad Abdullah Qureshi; Zara Ansari; Gustaf Drevin; Swagoto Mukhopadhyay; Mansoor Ali Khan; Muhammad Amin Chinoy; John Meara; Hamidah Hussain
Journal:  BMJ Open       Date:  2019-05-28       Impact factor: 2.692

Review 5.  Key Components, Current Practice and Clinical Outcomes of ERAS Programs in Patients Undergoing Orthopedic Surgery: A Systematic Review.

Authors:  Francesca Salamanna; Deyanira Contartese; Silvia Brogini; Andrea Visani; Konstantinos Martikos; Cristiana Griffoni; Alessandro Ricci; Alessandro Gasbarrini; Milena Fini
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

6.  A Patient-Focused Technology-Enabled Program Improves Outcomes in Primary Total Hip and Knee Replacement Surgery.

Authors:  Prakash Jayakumar; Jianing Di; Jiayu Fu; Joyce Craig; Vicki Joughin; Victoria Nadarajah; Jade Cope; Marcus Bankes; Peter Earnshaw; Zameer Shah
Journal:  JB JS Open Access       Date:  2017-07-25

7.  Enhanced recovery following hip and knee arthroplasty: a systematic review of cost-effectiveness evidence.

Authors:  Mark G Pritchard; Jacqueline Murphy; Lok Cheng; Roshni Janarthanan; Andrew Judge; Jose Leal
Journal:  BMJ Open       Date:  2020-01-15       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.